Human Pluripotent Stem Cell Differentiation into Pancreatic Endocrine Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating human pluripotent stem cells into pancreatic endocrine cells are inefficient and do not fully replicate the developmental program of higher mammals, such as humans, necessitating the development of improved conditions for expanding stem cell lines that can differentiate into pancreatic endocrine cells.
Innovation Solution
A method involving culturing human definitive endoderm cells with fibroblast growth factor 2 (FGF-2), retinoic acid, and activin A, followed by further differentiation in media with retinoic acid or retinoic acid and FGF-2, to produce pancreatic endocrine cells expressing NKX2.2 and belonging to the β-cell lineage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If human pluripotent stem cells are differentiated into pancreatic endocrine cells using conventional methods, then pancreatic endocrine cells are produced, but the differentiation efficiency is low and the developmental program does not fully replicate human development
Solution Approach 1:
The differentiation process is divided into distinct sequential stages: definitive endoderm formation, pancreatic endoderm specification, and pancreatic endocrine cell differentiation. Each stage uses specific growth factor combinations (Activin A for definitive endoderm, FGF2 and Retinoic Acid for pancreatic endoderm, followed by pancreatic endocrine differentiation) to guide cells through human-replicative developmental pathways, improving both efficiency and fidelity simultaneously
Solution Approach 2:
The invention optimizes multiple culture parameters including growth factor concentrations, culture medium composition, and differentiation timing to enhance differentiation efficiency while maintaining faithful replication of human pancreatic developmental programs
2Quantity of substance
If stem cell lines are expanded for clinical use, then sufficient cell numbers are obtained, but the ability to differentiate into pancreatic endocrine cells may be compromised
Solution Approach 1:
The invention establishes and maintains pluripotent stem cell lines with optimized characteristics before differentiation is initiated. By pre-characterizing and selecting stem cell lines with high differentiation potential, the method ensures that expanded cell populations retain the capacity to differentiate into pancreatic endocrine cells, addressing both quantity and adaptability requirements
Data Source
Figure 1a)~1b)
Figure 2a)~2c)
Figure 3A~3D
AI summary
The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.